Development and validation of the prognostic value of the immune-related genes in clear cell renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is a highly heterogeneous tumor, resulting a challenge of developing target therapeutics. Not long ago, immune checkpoint blockade regimens combine with tyrosin kinase inhibitors have evolved frontline options in metastatic RCC, which implies arriv...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Androl Urol
Hlavní autoři: Liao, Zhuangyao, Yao, Haohua, Wei, Jinhuan, Feng, Zihao, Chen, Wei, Luo, Junhang, Chen, Xu
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100830/
https://ncbi.nlm.nih.gov/pubmed/33968649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau-20-1348
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky